Upgrade to SI Premium - Free Trial

Sarepta Therapeutics (SRPT) PT Lowered to $48 at JMP Securities

March 1, 2017 7:11 AM
JMP Securities lowered its price target on Sarepta Therapeutics (NASDAQ: SRPT) to $48.00 (from $65.00) while maintaining a Market Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles